Your browser is no longer supported. Please, upgrade your browser.
Settings
BIOS BioScrip, Inc. daily Stock Chart
BIOS [NASD]
BioScrip, Inc.
Index- P/E- EPS (ttm)-0.47 Insider Own0.50% Shs Outstand127.61M Perf Week8.92%
Market Cap296.06M Forward P/E- EPS next Y-0.12 Insider Trans0.00% Shs Float127.29M Perf Month8.41%
Income-60.40M PEG- EPS next Q-0.09 Inst Own79.60% Short Float7.96% Perf Quarter8.41%
Sales719.30M P/S0.41 EPS this Y56.90% Inst Trans-3.88% Short Ratio7.54 Perf Half Y-40.36%
Book/sh-1.22 P/B- EPS next Y52.00% ROA- Target Price3.79 Perf Year-14.07%
Cash/sh0.04 P/C51.94 EPS next 5Y10.00% ROE- 52W Range1.56 - 4.14 Perf YTD-35.01%
Dividend- P/FCF- EPS past 5Y15.10% ROI1.50% 52W High-43.96% Beta0.51
Dividend %- Quick Ratio1.20 Sales past 5Y0.40% Gross Margin34.20% 52W Low48.72% ATR0.11
Employees1657 Current Ratio1.50 Sales Q/Q6.20% Oper. Margin- RSI (14)66.24 Volatility4.64% 5.11%
OptionableYes Debt/Eq- EPS Q/Q15.60% Profit Margin- Rel Volume0.25 Prev Close2.31
ShortableYes LT Debt/Eq- EarningsMar 15 BMO Payout- Avg Volume1.34M Price2.32
Recom1.70 SMA208.54% SMA5015.72% SMA200-20.12% Volume340,420 Change0.43%
Mar-18-19Reiterated Canaccord Genuity Buy $5 → $3.50
Mar-18-19Downgrade Stephens Overweight → Equal-Weight
Aug-10-17Upgrade SunTrust Hold → Buy
Mar-06-17Reiterated Barrington Research Outperform $1.50 → $2.25
Jan-03-17Initiated Lake Street Buy $4.50
Nov-08-16Resumed Jefferies Buy
Aug-12-15Reiterated Dougherty & Company Buy $7 → $4
Aug-11-15Downgrade Sun Trust Rbsn Humphrey Buy → Neutral
Feb-04-14Reiterated Dougherty & Company Buy $8 → $12
Nov-08-13Downgrade Feltl & Co. Strong Buy → Buy $11 → $7.50
Sep-25-13Reiterated Dougherty & Company Buy $15 → $10
Jun-18-13Reiterated Dougherty & Company Buy $15 → $20
Jun-17-13Reiterated Feltl & Co. Strong Buy $17 → $20
Apr-09-13Initiated Feltl & Co. Strong Buy $15
May-10-12Reiterated Dougherty & Company Buy $10 → $13
Sep-28-11Initiated BB&T Capital Mkts Buy $10
Aug-04-09Upgrade Piper Jaffray Neutral → Overweight
Sep-12-08Downgrade Piper Jaffray Buy → Neutral
Aug-13-08Initiated Noble Financial Buy $6.50
May-06-08Reiterated Broadpoint Capital Buy $9 → $6
Jun-18-19 06:14AM  BioScrip, Inc.'s Shares March Higher, Can It Continue? Zacks
Jun-13-19 09:00AM  Key Members of BioScrips Leadership Team to Continue in Executive Roles with Combined Company Following Close of Option Care Merger GlobeNewswire
Jun-10-19 11:47AM  RLH Corporation Announces Changes to Its Board of Directors GlobeNewswire
Jun-01-19 09:31AM  BioScrip (BIOS) Up 5.2% Since Last Earnings Report: Can It Continue? Zacks
May-21-19 09:00AM  BioScrip to Participate in Upcoming Investor Conferences GlobeNewswire
May-14-19 08:08PM  BioScrip, Inc. -- Moody's upgrades BioScrip, Inc.'s Corporate Family Rating to B3, outlook stable Moody's
May-09-19 08:59PM  Heres What Hedge Funds Think About BioScrip Inc. (BIOS) Insider Monkey
10:36AM  BioScrip's Option Care Merger on Track, Q1 Loss Narrows Zacks
May-03-19 11:00AM  MERGER INVESTIGATION NOTICE: Kaskela Law LLC Announces Shareholder Investigation of BioScrip, Inc. BIOS GlobeNewswire
May-02-19 10:33AM  BioScrip (BIOS) May Report Negative Earnings: Know the Trend Ahead of Q1 Release Zacks
08:35AM  BioScrip (BIOS) Reports Q1 Loss, Tops Revenue Estimates Zacks
07:27AM  BioScrip: 1Q Earnings Snapshot Associated Press
07:00AM  BioScrip Reports First Quarter 2019 Financial Results GlobeNewswire
Apr-23-19 09:00AM  BioScrip, Inc. Provides Merger Update GlobeNewswire +13.66%
Apr-18-19 04:46PM  HC Group Holdings III, Inc. -- Moody's announces completion of a periodic review of ratings of HC Group Holdings III, Inc. Moody's
Apr-16-19 09:39AM  Moving Average Crossover Alert: BioScrip Zacks
Apr-14-19 09:30AM  Why Is BioScrip (BIOS) Down 50.4% Since Last Earnings Report? Zacks
Apr-11-19 08:00AM  New Strong Sell Stocks for April 11th Zacks
Apr-09-19 07:26AM  New Strong Sell Stocks for April 9th Zacks -5.18%
Apr-01-19 08:54AM  New Strong Sell Stocks for April 1st Zacks
Mar-20-19 04:06AM  Edited Transcript of BIOS earnings conference call or presentation 15-Mar-19 1:00pm GMT Thomson Reuters StreetEvents -11.20%
Mar-18-19 04:44PM  BioScrip, Inc. -- Moody's places BioScrip's ratings under review for upgrade following the announced merger with HC Group Holdings Moody's -15.83%
12:43PM  HC Group Holdings III, Inc. -- Moody's places HC Group Holding's ratings under review for upgrade following the announced merger with BioScrip Moody's
12:23PM  BioScrip's stock extends plunge after merger terms disappoint, but analyst recommends remaining bullish MarketWatch
08:51AM  BioScrip (BIOS) Reports Loss in Q4, Both Margins Contract Zacks
08:44AM  Do Options Traders Know Something About BioScrip (BIOS) Stock We Don't? Zacks
08:05AM  Merger Agreement and Earnings Review in this Comprehensive Report on BioScrip ACCESSWIRE
Mar-15-19 04:33PM  Why Adobe, BioScrip, and Ascena Retail Group Slumped Today Motley Fool -20.34%
03:22PM  Bioscrip Inc (BIOS) Q4 2018 Earnings Conference Call Transcript Motley Fool
02:42PM  Why BioScrip Stock Popped and Then Dropped Today Motley Fool
09:32AM  Infusion Therapy Firm BioScrip to Buy Rival Option Care TheStreet.com
07:35AM  BioScrip's stock soars after merger deal with Option Care, owned by Walgreens and Madison Dearborn MarketWatch
07:30AM  BioScrip: 4Q Earnings Snapshot Associated Press
07:01AM  BioScrip Reports Fourth Quarter and Full Year 2018 Financial Results GlobeNewswire
07:00AM  Home and Alternate Site Infusion Therapy Providers BioScrip and Option Care to Merge GlobeNewswire
07:00AM  BioScrip, Inc. to Host Earnings Call ACCESSWIRE
Mar-13-19 10:11PM  BioScrip Reschedules Release of Fourth Quarter and Full Year 2018 Financial Results and Conference Call GlobeNewswire
Mar-08-19 11:12AM  What Kind Of Shareholders Own BioScrip, Inc. (NASDAQ:BIOS)? Simply Wall St.
Feb-25-19 02:00PM  BioScrip Schedules Release of Fourth Quarter and Full Year 2018 Financial Results and Conference Call GlobeNewswire
Jan-22-19 07:25AM  Report: Developing Opportunities within Macy's, Leggett & Platt, Tyler Technologies, BioScrip, DXC Technology, and STERIS plc Future Expectations, Projections Moving into 2019 GlobeNewswire
Jan-03-19 09:00AM  BioScrip to Present at the 37th Annual J.P. Morgan Healthcare Conference GlobeNewswire
Dec-18-18 02:55AM  Here is What Hedge Funds Think About BioScrip Inc. (BIOS) Insider Monkey
Dec-06-18 09:30AM  Why Is BioScrip (BIOS) Up 18.7% Since Last Earnings Report? Zacks
Nov-28-18 11:50AM  Biomedical Trends Fuel New Momentum For Healthcare Stocks; Premier Health Group, Inc. (OTC: PHGRF) (CSE: PHGI), Alliqua BioMedical, BioScrip, Coremedix ACCESSWIRE
Nov-26-18 04:30PM  BioScrip to Host Analyst and Investor Day GlobeNewswire +14.55%
12:55PM  4 Healthcare Stocks Seeing New Highs On Monday ACCESSWIRE
Nov-20-18 09:00AM  BioScrip to Present at the Bank of America Merrill Lynch 2018 Leveraged Finance Conference GlobeNewswire
Nov-16-18 10:50AM  4 Healthcare Stocks Turning Toward Tech For New Growth ACCESSWIRE
Nov-09-18 10:18AM  BioScrip (BIOS) Q3 Loss Wider Than Expected, Revenues Beat Zacks
Nov-07-18 09:30PM  Edited Transcript of BIOS earnings conference call or presentation 6-Nov-18 2:00pm GMT Thomson Reuters StreetEvents
Nov-06-18 09:40AM  BioScrip (BIOS) Reports Q3 Loss, Tops Revenue Estimates Zacks +14.23%
08:37AM  BioScrip: 3Q Earnings Snapshot Associated Press
08:00AM  BioScrip Reports Third Quarter 2018 Financial Results GlobeNewswire
Nov-01-18 08:00AM  BioScrip Comments on Implementation of Medicare Home Infusion Transition Benefit GlobeNewswire
Oct-25-18 09:00AM  BioScrip to Present at the 2018 Stephens NY Investment Conference GlobeNewswire
08:25AM  Factors of Influence in 2018, Key Indicators and Opportunity within Portola Pharmaceuticals, Cable One, Marriot Vacations Worldwide, United Technologies, Park-Ohio, and BioScrip New Research Emphasizes Economic Growth GlobeNewswire
Oct-24-18 09:00AM  BioScrip Schedules Release of Third Quarter 2018 Financial Results and Conference Call GlobeNewswire -5.76%
Oct-22-18 04:30PM  BioScrip Appoints John McMahon as Chief Accounting Officer GlobeNewswire
Oct-10-18 10:29AM  BioScrip Grows on CORE Plan, Reimbursement Issues Persist Zacks
Sep-06-18 10:17AM  BioScrip (BIOS) Up 4.8% Since Last Earnings Report: Can It Continue? Zacks
Sep-05-18 09:00AM  BioScrip to Participate in Upcoming Investor Conferences GlobeNewswire
07:30AM  Factors of Influence in 2018, Key Indicators and Opportunity within Aerie Pharmaceuticals, BioScrip, Celsion, Primoris Services, Cyclacel Pharmaceuticals, and Barnes Group New Research Emphasizes Economic Growth GlobeNewswire
Aug-16-18 11:45PM  Edited Transcript of BIOS earnings conference call or presentation 7-Aug-18 1:00pm GMT Thomson Reuters StreetEvents
08:25AM  Factors of Influence in 2018, Key Indicators and Opportunity within BioScrip, Powell Industries, Portola Pharmaceuticals, Daktronics, Cable One, and Park-Ohio New Research Emphasizes Economic Growth GlobeNewswire
Aug-08-18 10:25AM  BioScrip (BIOS) Q2 Loss Wider Than Expected, Revenues Top Zacks
Aug-07-18 09:25AM  BioScrip (BIOS) Reports Q2 Loss, Tops Revenue Estimates Zacks
08:22AM  BioScrip: 2Q Earnings Snapshot Associated Press
08:00AM  BioScrip Reports Second Quarter 2018 Financial Results GlobeNewswire
07:00AM  BioScrip, Inc. to Host Earnings Call ACCESSWIRE
Jul-30-18 05:06PM  BioScrip, Inc. -- Moody's upgrades BioScrip's CFR to Caa1; outlook stable Moody's
03:31PM  5 Stocks In Bearish Trends This Week Benzinga
08:30AM  BioScrip Appoints Leslie McIntosh as Chief Human Resources Officer GlobeNewswire
Jul-23-18 04:30PM  BioScrip to Present at the 38th Annual Canaccord Genuity Growth Conference GlobeNewswire
Jul-19-18 07:50AM  Initiating Free Research Reports on Horizon Pharma and Three Other Healthcare Equities ACCESSWIRE
Jul-18-18 04:30PM  BioScrip Schedules Release of Second Quarter 2018 Financial Results and Conference Call GlobeNewswire
Jul-13-18 07:26AM  Moving Average Crossover Alert: BioScrip (BIOS) Zacks
Jul-12-18 10:24AM  Here's Why You Should Invest in BioScrip (BIOS) Right Now Zacks
Jul-10-18 08:30AM  BioScrip Appoints Richard Denness as Chief Commercial Officer GlobeNewswire
Jul-05-18 09:19AM  Outpatient Market Gains on Social Awareness: 3 Stocks in Focus Zacks
Jun-11-18 06:12AM  Why Is BioScrip (BIOS) Down 2% Since its Last Earnings Report? Zacks
May-30-18 07:00AM  Free Daily Technical Summary Reports on CVS Health and Three Other Healthcare Stocks ACCESSWIRE +6.37%
May-28-18 04:02PM  Edited Transcript of BIOS earnings conference call or presentation 10-May-18 1:00pm GMT Thomson Reuters StreetEvents
May-16-18 09:00AM  BioScrip to Participate in Upcoming Investor Conferences GlobeNewswire
May-11-18 09:11AM  BioScrip (BIOS) Q1 Loss Wider Than Expected, Revenues Beat Zacks
May-10-18 09:24AM  BioScrip: 1Q Earnings Snapshot Associated Press
08:30AM  BioScrip Reports First Quarter 2018 Financial Results GlobeNewswire
May-03-18 08:15AM  Report: Developing Opportunities within Boston Private Financial, Ares Management, BioScrip, Glacier, CBIZ, and Powell Industries Future Expectations, Projections Moving into 2018 GlobeNewswire
Apr-26-18 04:30PM  BioScrip Schedules Release of First Quarter 2018 Financial Results and Conference Call GlobeNewswire
Apr-10-18 05:03PM  BioScrip Incs (NASDAQ:BIOS) Earnings Dropped -62.14%, Did Its Industry Show Weakness Too? Simply Wall St.
Apr-09-18 04:07AM  Why Is BioScrip (BIOS) Down 5.6% Since its Last Earnings Report? Zacks
Apr-04-18 07:20AM  Blog Exposure - Addus Homecare Completes Acquisition of Arcadia Home Care & Staffing for $18.5 Million ACCESSWIRE
Mar-26-18 06:30AM  BioScrip Timely Files Annual Form 10-K, Concludes Accounting Review and Provides Update on Immaterial Financial Statement Corrections GlobeNewswire +6.10%
Mar-21-18 08:20AM  New Research Coverage Highlights Real Goods Solar, LivePerson, Manhattan Associates, Natus Medical, BioScrip, and FBL Financial Group -- Consolidated Revenues, Company Growth, and Expectations for 2018 GlobeNewswire
Mar-20-18 03:09PM  Lifshitz & Miller LLP Announces Investigation of BioScrip, Inc., Civitas Solutions, Inc., Iridex Corp., OHR Pharmaceutical, Inc., Overstock.com, Inc., Syneos Health, Inc., Ubiquiti Networks, Inc. and WageWorks, Inc. PR Newswire
Mar-19-18 12:46PM  What does BioScrip Incs (NASDAQ:BIOS) Balance Sheet Tell Us About Its Future? Simply Wall St.
Mar-16-18 10:50AM  BioScrip's Dull 2017 Earnings a Woe, Core Business Robust Zacks
Mar-15-18 05:30PM  BioScrip Provides Update on Annual Form 10-K Filing Status Business Wire
Mar-14-18 02:58PM  Catalyst Pharmaceuticals Inc (CPRX) and Achillion Pharmaceuticals, Inc. (ACHN) Among Five Cheap Healthcare Stocks To Buy Now Insider Monkey
01:37PM  INVESTOR ALERT: Levi & Korsinsky, LLP Reminds Investors of an Investigation Involving Possible Securities Fraud Violations by the Board of Directors of BioScrip, Inc. -- BIOS Business Wire
08:44AM  Why BioScrip (BIOS) Could Be Positioned for a Slump Zacks
BioScrip, Inc. provides infusion and home care management solutions in the United States. It engages in the preparation, delivery, administration, and clinical monitoring of pharmaceutical treatments that are administered to a patient through intravenous, subcutaneous, intramuscular, intra-spinal, and enteral methods. The company is primarily involved in the intravenous administration of medications to treat a range of acute and chronic conditions, such as infections, nutritional deficiencies, immunologic and neurologic disorders, cancer, pain, and palliative care. It also offers home nursing products and services to patients suffering from chronic and acute medical conditions. The company provides its services at patient's home, outpatient clinics, nursing facilities, physician's offices, and ambulatory infusion centers. BioScrip, Inc. offers its solutions through sales and marketing representatives, and payor relationships. The company was incorporated in 1996 and is based in Denver, Colorado.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
GREENLEAF DANIEL EChief Executive OfficerMay 16Option Exercise0.00197,7270438,039May 20 08:12 PM
Deitsch StephenChief Financial OfficerMay 16Option Exercise0.0056,2630151,154May 20 08:02 PM
Deitsch StephenChief Financial OfficerApr 18Option Exercise0.0086,5870119,985Apr 22 06:18 PM
GREENLEAF DANIEL EChief Executive OfficerApr 18Option Exercise0.00234,6100308,306Apr 22 01:33 PM
Stalmack KathrynGeneral CounselApr 17Option Exercise0.009,843081,353Apr 18 06:12 PM
Booker HarrietChief Operating OfficerApr 17Option Exercise0.0033,627033,627Apr 18 07:54 PM
Kepler JodyChief Compliance OfficerApr 10Option Exercise0.0023,454023,454Apr 11 07:07 PM
Stalmack KathrynGeneral CounselApr 10Option Exercise0.0073,745093,745Apr 11 06:44 PM
Deitsch StephenChief Financial OfficerFeb 08Option Exercise0.0035,211045,211Feb 12 07:32 PM
GREENLEAF DANIEL EChief Executive OfficerFeb 08Option Exercise0.0064,350095,350Feb 12 07:04 PM